Still River Systems has reached a production milestone, clinical beam extraction from the first production unit of the world's smallest high-energy proton therapy accelerator.
Powerful proton beams are used for the precise treatment of cancer by delivering a highly focused beam of radiation to the tumor while reducing the damage to surrounding healthy tissue and vital organs, according to the Littleton, Mass. based Still River Systems.
Still River Systems said that the unique accelerator has been specially designed for the Monarch250 Proton Therapy System currently being installed at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, MO, a National Cancer Institute (NCI) Comprehensive Cancer Center.
The Robert Wood Johnson University Hospital and the University of Oklahoma Medical Center are two other centers that are currently constructing a proton therapy center to take delivery of Still River Systems revolutionary proton technology.